Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ethinylestradiol + gestodene
- Development stage
- Unknown
- Lead developer
- Bayer HealthCare Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Transdermal
01
Overview
Ethinylestradiol + gestodene is a combined hormonal contraceptive transdermal patch developed by Bayer. It contains a low-dose combination of the estrogen ethinylestradiol and the progestin gestodene. The patch is designed for once-weekly application, providing continuous transdermal delivery of hormones to inhibit ovulation by suppressing the hypothalamic-pituitary-ovarian axis. It was developed as a transparent, low-dose alternative to existing contraceptive patches, with clinical studies demonstrating efficacy in pregnancy prevention and cycle control comparable to oral contraceptives.
- Brand names
- Lisvy
- Other names
- Ethinylestradiol/Gestodene transdermal patch
02
Targets
PR (Progesterone receptor)ER (Estrogen receptor)AR (Adrenergic receptors)
Beyond the preview
Go deeper on ethinylestradiol + gestodene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ethinylestradiol + gestodene.